Crescent Capital BDC Reports Decline in Net Assets and NAV, Increase in Non-Accrual Investments

summarizeSummary

Crescent Capital BDC, Inc. reported a decline in net assets and net asset value per share for Q1 2026, alongside an increase in non-accrual investments, signaling deteriorating portfolio health.

check_boxKey Events

• Net Assets from Operations Decline

  Net increase (decrease) in net assets resulting from operations swung from a $3.904 million gain in Q1 2025 to a $15.513 million loss in Q1 2026.

• Net Asset Value (NAV) Per Share Decreased

  NAV per share decreased to $18.27 as of March 31, 2026, from $19.10 at December 31, 2025.

• Increase in Non-Accrual Investments

  Non-accrual investments increased to 5.7% of total debt investments at cost (3.6% at fair value) as of March 31, 2026, up from 4.1% (2.0% at fair value) at December 31, 2025. The number of portfolio companies on non-accrual status rose from 11 to 13.

• Increased Management Fee Waivers

  The Adviser waived $1.412 million in income incentive fees in Q1 2026, a significant increase from $32k waived in Q1 2025, to support net investment income.

auto_awesomeAnalysis

Crescent Capital BDC, Inc.'s Q1 2026 results show a significant deterioration in portfolio health and overall financial performance. The swing from a positive net increase in net assets from operations in Q1 2025 to a substantial loss in Q1 2026, coupled with a decline in Net Asset Value per share, indicates a challenging quarter. Most concerning is the notable increase in non-accrual investments, which points to worsening credit quality within the portfolio. While the increased management fee waiver helps mitigate the impact on distributable income, it underscores the underlying performance issues. The share repurchases are a positive signal of management's belief in the company's value, but they are relatively small compared to the overall negative trends.